A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis.
Kiana KreitzAngela ErnstRené SchmidtThorsten SimonMatthias FischerRuth VollandBarbara HeroFrank BertholdPublished in: Cancer medicine (2019)
A new risk score system for patients with first recurrence of stage 4 neuroblastoma aged ≥18 months at diagnosis is proposed.